TRANSCRIPT

Q4 2021 — Earnings call remarks

Q4 2021PDF · 9 pages153 KB
Earnings Conference Call
Fourth Quarter 2021 Remarks
January 19, 2022
Moderator:
Good morning, and welcome to the UnitedHealth Group Fourth Quarter and Full Year 2021
Earnings Conference Call. A question and answer session will follow UnitedHealth Group’s
prepared remarks. As a reminder, this call is being recorded.
Here is some important introductory information. This call contains “forward-looking” statements
under U.S. federal securities laws. These statements are subject to risks and uncertainties that
could cause actual results to differ materially from historical experience or present expectations.
A description of some of the risks and uncertainties can be found in the reports that we file with
the Securities and Exchange Commission, including the cautionary statements included in our
current and periodic filings.
This call will also reference non-GAAP amounts. A reconciliation of the non-GAAP to GAAP
amounts is available on the “Financial & Earnings Reports” section of the Company’s Investor
Relations page at www.unitedhealthgroup.com.
Information presented on this call is contained in the Earnings Release we issued this morning
and in our Form 8-K dated January 19, 2022, which may be accessed from the Investor
Relations page of the Company’s website. I will now turn the conference over to the chief
executive officer of UnitedHealth Group, Andrew Witty.
Andrew Witty:
Good morning and thank you all for joining us today.
I’d like to start by recognizing my colleagues — the people of Optum and
UnitedHealthcare — for delivering strong results throughout 2021 and creating the
momentum that is carrying through as we enter this year.
For example, performance in two key elements of our growth strategy — accelerating
the transition of patients to Optum-led value-based care and strong
UnitedHealthcare growth in serving Medicare Advantage consumers — are both

-- 1 of 9 --

2
tracking well with the expectations we shared with you at our recent investor
conference.
These — and the broader performance across the enterprise — confirm our confidence
in our ability to advance our stated growth strategies … and to support our long-term
13% to 16% EPS growth rate.
When you look back at the prevailing themes for 2021, you see a story of accelerating
growth. Strong collaboration between Optum and UnitedHealthcare and with our many
external partners helped us grow in serving both commercial and government markets,
unlock new innovation, introduce integrated products and services to the marketplace
and significantly increase the number of people benefiting from value-based models of
care.
Last year, we leveraged our technology capabilities to help physician and hospital
systems better serve their patients and communities. And we sharpened our focus on
the consumer — working to elevate and improve the end-to-end experience. Taken
together, these efforts helped us add more than $30 billion in revenue for the year —
about $10 billion above our initial outlook.
And you should expect similar growth in the year ahead. We see an even greater
demand for integration, to bring together the fragmented pieces of the health
system … to harness the tremendous innovation occurring in the marketplace … to help
better align the incentives for providers, payers and consumers … and to organize the
system around value. A health care system that is more connected, more informed,
more human — and more responsive to every person’s unique needs.
At our investor conference, we shared five key areas for growth and for differentiated
experiences across our portfolio. These growth opportunities will guide our strategy this
year and for many years to come.

-- 2 of 9 --

3
First is care delivery, more specifically, value-based care. For UnitedHealth Group this
is more than a primary care strategy; it is a comprehensive clinical strategy
encompassing our growing behavioral, home, ambulatory and virtual care capabilities.
Our second growth area is health benefits — advancing the quality, innovation and
consumer appeal of our benefit offerings and bringing our value-based strategy to life.
We enter ’22 having generated strong consumer growth in Medicare Advantage and
saw further progress in Medicaid and growing momentum in our commercial business.
Next: Health technology. Our major partnerships across the country help health systems
improve their performance and returns — all to better support their missions. We are
energized by the potential to bring these comprehensive, tailored solutions to a greater
number of system partners in 2022 and beyond.
Fourth: Health financial services — vastly improving the health payments sector —
streamlining and simplifying payments for providers, payers and consumers … while
reducing friction and increasing speed and convenience.
And finally: Pharmacy services — where people interact most often with the health care
system. We can better use the significant breadth, volume and value of our foundational
pharmacy services and data capabilities, and integrate our medical, pharmacy and
behavioral capabilities — all of this to provide whole-person care, support the discovery
of new drugs and treatments, and support value-based models of care.
In sum: We enter 2022 with heightened confidence in our ability to execute upon the
objectives we set forth in late November.
And with that, I’ll turn it over to President and Chief Operating Officer Dirk McMahon.

-- 3 of 9 --

4
Dirk McMahon:
Thank you, Andrew.
I thought I would take a few minutes providing you with some additional details on our
first growth priority, value-based care: how we have prepared for it, the investments we
have made and how we see it working in the near future. This has been something we
have been working on and building over the course of a decade.
For example, there was significant operational groundwork and investment that went
into supporting the half-million new patients for whom Optum Health will become
accountable in 2022. Successful execution requires a lot of detailed planning, investing
and building. It has become a distinctive competency of our enterprise, which we can
now increasingly apply at scale.
So what does it take to prepare for moving to a fully accountable arrangement? The
investments can be significant; as an example, in 2021, we incurred over $100 million in
preparation expense. Within this, there are three major workstreams involved: clinical
training and staff preparation, technology and data enhancement, and third is network
coordination.
The first work stream focuses on physician education and begins well more than a year
prior. It’s important to provide the resources and knowledge for physicians to begin
approaching their patients differently. They engage in their patients’ “whole health” well
ahead of taking on greater accountability. We find it to be an essential and sometimes
complex shift in what are long-held fee-for-service practices. Beyond education, we
ramp up our capacity in the form of physicians, nurses and other clinicians to meet the
requirements of our business.
The second area focuses on the technology systems and information needed to support
patient care and effective clinical management. This includes things like patient portals

-- 4 of 9 --

5
and utilization management systems, as well as reporting systems for teams to
effectively manage.
Finally, is the planning and network coordination work to support clinical oversight
beyond primary care and ensure true continuity of care. This planning and coordination
includes initiatives such as:
• identifying the patients most in need and ensuring a seamless transition to high-
touch clinical care services that improve health;
• and quickly pairing patients with a personal care navigator to assist in supporting
complex health needs, appointment scheduling and timely medication support on
day one.
These foundational preparations and investments have been critical in creating strong
results across the variety of geographies and practices we have transitioned. We expect
this expertise will serve us well as we transition even larger groups of patients in the
years to come.
Before handing it over to John, I’ll update you on how COVID has impacted our
operations. Like other businesses, we have experienced moderately higher levels of
attrition and more unplanned absences.
We had prepared for this situation through increased recruiting capacity as well as
meaningfully upgraded digital capabilities to improve customer experience and reduce
call volumes. As a result, in the first two weeks of 2022 — traditionally our most
demanding period — we were able to service the needs of our patients and customers.
At the same time, we responded swiftly to the federal mandate for cash-free COVID
tests for consumers — a highly complex undertaking. With four days’ notice,
UnitedHealthcare created a customer digital experience for ease of reimbursement and
established a partnership with Walmart, and now Rite Aid, that eliminates cash outlays

-- 5 of 9 --

6
by consumers at point of purchase. We expect more partnerships in the days ahead.
As we look forward, we believe we have the right capacity in place to execute our
business priorities and meet our customers’ expectations.
With that, now I’ll turn it over to Chief Financial Officer John Rex.
John Rex:
Thank you Dirk, and happy New Year everyone.
I’ll start by expanding a bit upon on Dirk’s comments on the COVID impacts we are
seeing.
In the most recent weeks, inpatient hospitalization levels for our members are similar to
the January 2021 levels, even with national COVID case rates about four times higher.
For those people needing inpatient care, severity is seemingly lower, as we are seeing
shorter lengths-of-stay compared to that earlier period.
At the same time, we are observing familiar correlations of care activity patterns to other
periods of elevated infection rates experienced over the past two years.
For example, in these early weeks of January, we are seeing slowing in primary care,
elective visit and procedural volumes. Activity over the past several weeks shows
primary care visits having declined about 10% and an even higher rate of decline in
specialist visits.
As always, our prime focus is on helping people get the care they need … when they
need it.
Moving now to our specific business performance:

-- 6 of 9 --

7
Optum Health’s revenue per consumer grew by over 30% in 2021, driven by the
increasing number of our patients served under value-based arrangements. Consistent
with the expectations we shared in late November, we had a strong start to the year and
continue to expect to add 500,000 new patients in accountable, value-based
relationships, benefiting from the groundwork laid over the past many years.
Optum Insight’s earnings grew 25% in ’21, with operating margins approaching 28% for
the year. We ended the year with a revenue backlog of $22.4 billion, an increase of
$2.2 billion over the prior year. Our expanding relationships serving health systems has
been a key factor driving this growth and we expect these partnerships to continue to
grow in ’22 and beyond.
Optum Rx earnings grew 6% for the year, driven by the continued expansion of our
pharmacy services businesses, supply chain initiatives and strong cost management
activities … and benefiting from strong customer retention. In addition, we continue to
see the impact of Optum Rx’s movement to a higher-value pharmacy care and specialty
services orientation.
Turning to UnitedHealthcare, full year revenues of $223 billion grew 11%.
As noted, our 2022 Medicare Advantage member growth outlook is very positive and
consistent with the objectives we established at our November investor conference.
Within the up to 800,000 new members we will serve in ’22, about three quarters will be
in Individual and Group Medicare Advantage and the remainder in Dual Special Needs
Plans.
And given the steady strides we have made in quality performance, we have the
opportunity to enroll people in our newly rated 5-Star plans throughout the entirety of
this year.

-- 7 of 9 --

8
Our Medicaid membership outlook for ’22 continues to incorporate an expectation that
states resume eligibility redeterminations, resulting in modest net attrition. In January
we began serving the citizens of Minnesota and continue to support the Missouri
expansion this year, as well as renewed relationships with Ohio, Tennessee and
Nevada.
Over the course of the year, we will look to continue to expand upon the nearly 8 million
individuals we serve across 31 states.
We concluded ’21 with commercial membership about 200,000 people ahead of the
original outlook provided. Creating this momentum is the strong response we are seeing
to the new, innovative products you have heard us discuss; products such as
NavigateNow, which use the Optum Virtual network as a first option.
Our capital capacities remain strong. Full year ’21 cash flow from operations was
$22.3 billion, or 1.3 times net income, about $2 billion above the initial outlook we
shared a year ago. We continue to expect our 2022 cash flow to approach $24 billion,
about 1.2 times net income.
And we ended 2021 with a debt to total capital ratio of 38%.
These ample capital capacities allow us to continue to accelerate our investments while
remaining committed to an advancing shareholder dividend and supporting our
expected repurchase of between $5 and $6 billion of stock in ’22.
Our 2022 adjusted earnings per share outlook of $21.10 to $21.60 is consistent with the
view we offered seven weeks ago.
From this distance, in contrast to the past two years we expect the seasonal pattern to
be more consistent with our historical experience, with just under 50% of full year
earnings in the first half and the first two quarters comparably even.

-- 8 of 9 --

9
Now I’ll turn it back to Andrew.
Andrew Witty:
Before we transition to the Q&A portion of the call, I hope you’ve taken away the strong
sense of confidence John, Dirk and I share in the growth potential of this company —
rooted in the growing number of people we’re serving in value-based models, the depth
of relationships we’re building with local health systems, our pharmacy capabilities and
the innovation and consumer focus that’s driving growth across our government
programs, individual and commercial businesses.
As demand for innovation and integrated solutions, products and services only
continues to grow … we’ve never been in a better position to help bring together the
fragmented pieces of health care and create more value for the people we try to serve.

-- 9 of 9 --